West Virginia revealed as the state with the highest number of GLP-1 users amidst celebrity usage controversy

- West Virginia has the highest number of GLP-1 users, with 24,217.07 GLP-1 prescriptions per 100,000 residents.
- Kentucky has the second-highest number of users, with 22,003.90 GLP-1 prescriptions per 100,000.
- Hawaii has the lowest number of users, with 5,050.46 GLP-1 prescriptions per 100,000.
A new study has revealed the states with the highest number of GLP-1 users. GLP-1 drugs include Ozempic, Wegovy, and Mounjaro, and are used by many for weight loss.
The research, conducted by personal injury lawyers Whitley Law Firm, examined the prescription numbers for GLP-1 prescriptions dispensed in 2024, scaled to local populations to establish a prescription rate per 100,000 residents in each state.
West Virginia has the highest number of GLP-1 users, with 24,217.07 GLP-1 prescriptions dispensed per 100,000 residents. The number of GLP-1 prescriptions in 2024 reached 428,367, representing a 3.2% decrease from 2023.
Kentucky has the second-highest number of users, with 22,003.90 GLP-1 prescriptions dispensed per 100,000 residents in 2024. 1,009,621 prescriptions were dispensed in 2024, a 2.6% increase from 2023.
In third place is Louisiana, where 20,282.44 GLP-1 prescriptions per 100,000 residents were dispensed in 2024. In this state, a total of 932,543 GLP-1 prescriptions were dispensed, representing an 11.6% decrease.
Ranking fourth is Oklahoma, which recorded 19,504.89 GLP-1 prescriptions dispensed per 100,000 residents. Oklahoma saw a 16.8% increase in the number of GLP-1 prescriptions from 2023-2024, with 798,802 prescriptions dispensed in 2024.
Coming in fifth is Alabama, with 19,260.64 GLP-1 prescriptions dispensed per 100,000 residents. The number of GLP-1 prescriptions in this state rose slightly from 2023, by 0.4%, with a total of 993,406 dispensed in 2024.
Mississippi is in sixth place, with 18,745.96 GLP-1 prescriptions dispensed per 100,000 residents. In this state, the number of GLP-1 prescriptions dispensed in 2024 topped 551,702, an increase of 2.0% from 2023.
Next up is North Dakota, where 17,840.03 GLP-1 prescriptions were dispensed per 100,000 residents. 142,108 GLP-1 prescriptions were dispensed in 2024, representing a 20.8% increase from 2023.
Alaska ranks eighth, with 17,383.09 GLP-1 prescriptions dispensed per 100,000 residents in 2024. In this state, 128,658 GLP-1 prescriptions were dispensed in 2024, representing a 21.8% increase from 2023, the largest increase in this top ten listing.
In ninth place is Arkansas, with 17,346.00 GLP-1 prescriptions dispensed per 100,000 residents. 535,706 prescriptions were dispensed in 2024, a 1.4% decrease from 2023.
Finally, rounding off the top ten is Pennsylvania, with 17,131.12 GLP-1 prescriptions per 100,000 residents dispensed in 2024. 2,240,537 GLP-1 prescriptions were dispensed in 2024, an 8.8% increase from 2023.
On the other end of the scale, Hawaii has the lowest number of GLP-1 users, with 5,050 GLP-1 prescriptions dispensed per 100,000 residents. A total of 73,037 prescriptions were dispensed in 2024, a 21.0% increase from 2023.
The 10 states with the most GLP-1 prescriptions in 2024
| State | GLP-1 Prescriptions Dispensed in 2024 (Per 100,000 Residents) | Percentage Change (2023 to 2024) | |
| 1 | West Virginia | 24,217.07 | -3.2% |
| 2 | Kentucky | 22,003.90 | 2.6% |
| 3 | Louisiana | 20,282.44 | -11.6% |
| 4 | Oklahoma | 19,504.89 | 16.8% |
| 5 | Alabama | 19,260.64 | 0.4% |
| 6 | Mississippi | 18,745.96 | 2.0% |
| 7 | North Dakota | 17,840.03 | 20.8% |
| 8 | Alaska | 17,383.09 | 21.8% |
| 9 | Arkansas | 17,346.00 | -1.4% |
| 10 | Pennsylvania | 17,131.12 | 8.8% |
Commenting on the study, a spokesperson from Whitley Law Firm said:
“It’s interesting to see the varying rates of GLP-1 prescriptions across the U.S., highlighting the states where medications like Ozempic are most commonly used. With West Virginia leading the rankings, the differences may be due to a range of factors, including healthcare access, lifestyle, and medical needs.
“As the conversation around GLP-1 medications continues, it’s important to consider the factors driving these trends. Understanding these patterns can help inform future discussions on public health and medical accessibility.”
-ENDS-
If you use this story, please credit and link to https://whitleylawfirm.com. A linked credit allows us to keep supplying you with future content that you may find useful.
Sources: www.axios.com
Methodology:
Axios provides prescription numbers for GLP-1 drugs dispensed in 2024, divided by state (https://www.axios.com/local/nw-arkansas/2025/01/09/mapped-weight-loss-drugs). This data is pulled from the Purple Labs prescription database.
Full state ranking
| State | GLP-1 Prescriptions Dispensed in 2024 (Per 100,000 Residents) | Percentage Change (2023 to 2024) | |
| 1 | West Virginia | 24,217.07 | -3.20% |
| 2 | Kentucky | 22,003.90 | 2.60% |
| 3 | Louisiana | 20,282.44 | -11.60% |
| 4 | Oklahoma | 19,504.89 | 16.80% |
| 5 | Alabama | 19,260.64 | 0.40% |
| 6 | Mississippi | 18,745.96 | 2.00% |
| 7 | North Dakota | 17,840.03 | 20.80% |
| 8 | Alaska | 17,383.09 | 21.80% |
| 9 | Arkansas | 17,346.00 | -1.40% |
| 10 | Pennsylvania | 17,131.12 | 8.80% |
| 11 | Iowa | 16,266.02 | 14.40% |
| 12 | Michigan | 15,780.56 | 5.40% |
| 13 | Kansas | 15,320.65 | 7.40% |
| 14 | Georgia | 15,249.53 | 11.10% |
| 15 | Texas | 14,908.07 | 4.80% |
| 16 | Tennessee | 14,893.81 | 4.20% |
| 17 | Idaho | 14,439.86 | -10.90% |
| 18 | Ohio | 14,255.93 | 6.90% |
| 19 | New York | 14,196.83 | 15.10% |
| 20 | New Jersey | 14,049.33 | 35.80% |
| 21 | Missouri | 13,967.83 | 7.20% |
| 22 | South Carolina | 13,613.05 | 9.30% |
| 23 | Nebraska | 13,560.40 | 9.00% |
| 24 | Connecticut | 13,129.49 | 12.70% |
| 25 | Illinois | 12,892.06 | 13.80% |
| 26 | Maine | 12,720.53 | 27.20% |
| 27 | Indiana | 12,699.19 | 0.80% |
| 28 | North Carolina | 12,334.49 | 5.70% |
| 29 | Wyoming | 12,242.99 | 17.10% |
| 30 | New Mexico | 12,217.31 | 20.40% |
| 31 | Virginia | 11,687.53 | 9.00% |
| 32 | Vermont | 11,516.08 | -1.70% |
| 33 | Minnesota | 11,440.58 | 13.00% |
| 34 | New Hampshire | 11,281.01 | 15.30% |
| 35 | Montana | 11,094.91 | 7.30% |
| 36 | Massachusetts | 10,892.70 | 48.00% |
| 37 | South Dakota | 10,872.32 | -11.10% |
| 38 | Delaware | 10,846.96 | 4.70% |
| 39 | Florida | 10,390.41 | 23.70% |
| 40 | Wisconsin | 9,978.32 | 21.80% |
| 41 | Maryland | 9,644.91 | 22.60% |
| 42 | California | 9,462.74 | 5.40% |
| 43 | Washington | 9,015.30 | 8.40% |
| 44 | Utah | 8,536.16 | 6.20% |
| 45 | Arizona | 8,100.01 | 12.60% |
| 46 | Oregon | 7,920.36 | 12.60% |
| 47 | Colorado | 7,795.29 | 17.20% |
| 48 | Rhode Island | 7,501.16 | 67.80% |
| 49 | Nevada | 7,431.11 | 5.10% |
| 50 | Hawaii | 5,050.46 | 21.00% |
If you appreciate BBG's work, please support us with a contribution of whatever you can afford.
Support our stories